The Board of the Affidea Group BV are pleased to announce the appointment of Mr. Giuseppe Recchi as the new Chief Executive Officer of the Group, effective immediately.
Giuseppe Recchi joins Affidea from Telecom Italia, where, since September 2017, he has been Deputy Chairman; having previously been Executive Chairman since April 2014. Prior to that, he was Chairman of the Board of Eni SpA from 2011 to 2014, before which he was at General Electric (GE), which he joined in 1999. There, he served as CEO of GE Capital Structure Finance Italia and as Managing Director for M&A in EMEA, before being appointed as President and CEO of GE South Europe. On 1 June 2017, he was awarded the title of ‘Cavaliere del Lavoro’ (Order of Merit for Labour) by decree of the President of the Italian Republic.
Richard Smith, Affidea’s Chairman, said; “Giuseppe is a world-class executive, and the Board and I are delighted he is joining us to lead the Affidea team. In Giuseppe, we have found exactly the right person to drive Affidea forward to realise its ambitions, and the Board and I are excited to begin this new phase of the group’s development with his experience and vision at the helm.”
Giuseppe Recchi said; “I am delighted to be joining Affidea and am looking forward to working with its hugely talented and dedicated #AffideaFamily. The vision of the Board and company shareholders is of a scale and purpose that matches my own, and I am eager to get started. I join a business that is in a strong position in all of its current areas of operation and I will be focusing my efforts on ensuring Affidea continues to deliver excellence to its customers in its existing and new markets, as well as helping it innovate and grow its role as a provider of superb healthcare.”
About the Affidea Group
Affidea is the leading Pan-European provider of diagnostic imaging and cancer treatment services, operating in 16 countries across Europe, with a focus on delivering timely, thorough diagnoses and high quality treatments by working only with state-of-the-art technology and experienced medical professionals. The Affidea Group employs almost 5,000 medical professionals and operates over 1,100 diagnosis and cancer care modalities with over 10 million diagnostic examinations every year. Affidea is owned by the trusts and funds associated with the Bertarelli family, which are managed by Waypoint Capital.